Related references
Note: Only part of the references are listed.Cyclophilin A Inhibitors Suppress Proliferation and Induce Apoptosis of MKN45 Gastric Cancer Stem-like Cells by Regulating CypA/CD147-Mediated Signaling Pathway
Hee Jeong Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells
Jang Mi Han et al.
CANCERS (2022)
Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Yue Zheng et al.
FRONTIERS IN ONCOLOGY (2022)
Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
Jang Mi Han et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Identification of Cyclophilin A as a Potential Anticancer Target of Novel Nargenicin A1 Analog in AGS Gastric Cancer Cells
Jang Mi Han et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of OCT4 in cancer stem-like cells and chemotherapy resistance
Ismail S. Mohiuddin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Characterization of Tailoring Steps of Nargenicin A1 Biosynthesis Reveals a Novel Analogue with Anticancer Activities
Dipesh Dhakal et al.
ACS CHEMICAL BIOLOGY (2020)
Novel Nargenicin A1 Analog Inhibits Angiogenesis by Downregulating the Endothelial VEGF/VEGFR2 Signaling and Tumoral HIF-1α/VEGF Pathway
Jang Mi Han et al.
BIOMEDICINES (2020)
CD44 mediates stem cell mobilization to damaged lung via its novel transcriptional targets, Cortactin and Survivin
Allal Ouhtit et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer
Jordi Codony-Servat et al.
CLINICAL LUNG CANCER (2019)
Effect of Cyclophilin from Pyropia Yezoensis on the Proliferation of Intestinal Epithelial Cells by Epidermal Growth Factor Receptor/Ras Signaling Pathway
Jae-Hun Jung et al.
MARINE DRUGS (2019)
Clinical and Therapeutic Implications of Cancer Stem Cells
Michael F. Clarke
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
Ping-Chih Hsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
Alejandro Herreros-Pomares et al.
CELL DEATH & DISEASE (2019)
Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas
Hui-Min Lei et al.
THERANOSTICS (2019)
LUNG CANCER Frontline immunotherapy for NSCLC: alone or not alone?
Cesare Gridelli et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Afatinib Plus Bevacizumab Combination After Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Multicenter, Single-Arm, Phase 2 Trial (ABC Study)
Akito Hata et al.
CANCER (2018)
Potential mechanisms of CD133 in cancer stem cells
Jae-Woo Jang et al.
LIFE SCIENCES (2017)
Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy
Boksoon Chang et al.
ONCOTARGETS AND THERAPY (2017)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
Giustina Ferone et al.
CANCER CELL (2016)
Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3
Jiawei Shou et al.
CANCER LETTERS (2016)
Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling
Bao-Qing Xu et al.
ONCOTARGET (2016)
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
Xun Chen et al.
JOURNAL OF CANCER (2016)
Formation of Tumorspheres with Increased Stemness without External Mitogens in a Lung Cancer
Juan Sebastian Yakisich et al.
STEM CELLS INTERNATIONAL (2016)
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Laetitia Seguin et al.
TRENDS IN CELL BIOLOGY (2015)
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
Chong Sun et al.
CELL REPORTS (2014)
CD147-Dependent Heterogeneity in Malignant and Chemoresistant Properties of Cancer Cells
Lu Dai et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness
G. Daniel Grass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer
Cheng-Ying Xie et al.
ANTI-CANCER DRUGS (2012)
Determining Mammosphere-Forming Potential: Application of the Limiting Dilution Analysis
Lauren M. Rota et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
Cancer Stem Cells and Self-renewal
Catherine Adell O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
David Jackman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling
Martin Peifer et al.
PLOS ONE (2010)
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Elaine Lai-Han Leung et al.
PLOS ONE (2010)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method
Ruta Gupta et al.
MODERN PATHOLOGY (2009)
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang et al.
MOLECULAR CANCER RESEARCH (2009)
Identification and expansion of the tumorigenic lung cancer stem cell population
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2008)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Correlation between survivin expression and prognosis in non-small cell lung cancer
Sukran Atikcan et al.
RESPIRATORY MEDICINE (2006)
Active site residues of cyclophilin A are crucial for its signaling activity via CD147
V Yurchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A
T Pushkarsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cyclophilin A is a secreted growth factor induced by oxidative stress
ZG Jin et al.
CIRCULATION RESEARCH (2000)
Enzymes that catalyse the restructuring of proteins
C Schiene et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2000)
Share Paper
